Mitotane

CHEMBL1670 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
320.0 g/mol
LogP
6.2
Phase
4

This medication damages the outer layer of the adrenal gland, reducing the production of steroid hormones and directly killing adrenal cancer cells. It is used to treat adrenal cortex cancer and to control excess hormone production from adrenal tumors.

आणविक भार

320.0000 g/mol

LogP

6.20

TPSA

0.00 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1

InChI

InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H

Molecular Formula

C14H10Cl4

HBD / HBA

- / -

घूर्णनीय बंधन

3

भारी परमाणु

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

This medication damages the outer layer of the adrenal gland, reducing the production of steroid hormones and directly killing adrenal cancer cells. It is used to treat adrenal cortex cancer and to control excess hormone production from adrenal tumors.

Yes, Mitotane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1670. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4211. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.